Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Crohn's-associated chronic recurrent multifocal osteomyelitis responsive to infliximab.

Carpenter E, Jackson MA, Friesen CA, Scarbrough M, Roberts CC.

J Pediatr. 2004 Apr;144(4):541-4.

PMID:
15069408
2.

[Indications and results of infliximab in Crohn's disease].

Karoui S, Boubaker J, Filali A.

Tunis Med. 2004 Dec;82(12):1057-63. Review. French.

PMID:
15822505
3.

[Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].

Tilg H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W; Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH.

Z Gastroenterol. 2004 Oct;42(10):1256-63. Review. German. No abstract available.

PMID:
15508068
4.

Guidelines for treatment with infliximab for Crohn's disease.

Hommes DW, Oldenburg B, van Bodegraven AA, van Hogezand RA, de Jong DJ, Romberg-Camps MJ, van der Woude J, Dijkstra G; Dutch Initiative on Crohn and Colitis (ICC).

Neth J Med. 2006 Jul-Aug;64(7):219-29. Review.

5.

Maintenance of remission in Crohn's disease: current and emerging therapeutic options.

Brookes MJ, Green JR.

Drugs. 2004;64(10):1069-89. Review.

PMID:
15139787
6.

[Infliximab--practical guidelines for the treatment of Crohn's disease].

Bauerfeind P, Beglinger C, Beltinger J, Braegger C, Eigenmann F, Fried M, Guyot J, Hürlimann R, Michetti P, Seibold F, Straumann A.

Rev Med Suisse. 2006 Jul 26;2(74):1807-15. Review. French.

PMID:
16927560
7.

Prediction of response to infliximab in Crohn's disease.

Chaudhary R, Ghosh S.

Dig Liver Dis. 2005 Aug;37(8):559-63. Review. No abstract available.

PMID:
15893967
8.

Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.

Lichtenstein GR.

Am J Gastroenterol. 2005 Jul;100(7):1433-5. Review. No abstract available.

PMID:
15984959
9.

Infliximab therapy for pediatric Crohn's disease.

Veres G, Baldassano RN, Mamula P.

Expert Opin Biol Ther. 2007 Dec;7(12):1869-80. Review.

PMID:
18034652
10.

Biological therapy in the management of recent-onset Crohn's disease: why, when and how?

Löwenberg M, Peppelenbosch M, Hommes D.

Drugs. 2006;66(11):1431-9. Review.

PMID:
16906776
11.

Infliximab use in luminal Crohn's disease.

Richter JA, Bickston SJ.

Gastroenterol Clin North Am. 2006 Dec;35(4):775-93. Review.

PMID:
17129813
12.

Infliximab use in Crohn's disease.

Bewtra M, Lichtenstein GR.

Expert Opin Biol Ther. 2005 Apr;5(4):589-99. Review.

PMID:
15934836
13.

New patients: should children be treated differently?

Dubinsky MC.

Colorectal Dis. 2006 May;8 Suppl 1:15-9. Review.

PMID:
16594959
14.

Infliximab in fistulizing Crohn's disease.

Osterman MT, Lichtenstein GR.

Gastroenterol Clin North Am. 2006 Dec;35(4):795-820. Review.

PMID:
17129814
15.

Infliximab use in patients with Crohn's disease: quality of life, costs and resource use.

Koelewijn C, Schrijvers A, Oldenburg B.

Neth J Med. 2006 Jul-Aug;64(7):212-8. Review. No abstract available.

16.

Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.

Loftus EV.

Am J Gastroenterol. 2005 Jul;100(7):1435-8. Review. No abstract available.

PMID:
15984960
17.

Neutrophilic dermatosis-associated sterile chronic multifocal osteomyelitis in pediatric patients: case report and review.

Nurre LD, Rabalais GP, Callen JP.

Pediatr Dermatol. 1999 May-Jun;16(3):214-6. Review.

PMID:
10383779
18.

[Management of Crohn's disease by immunoregulatory therapy].

Inoue N, Ogata H.

Nihon Shokakibyo Gakkai Zasshi. 2010 Jun;107(6):868-75. Review. Japanese. No abstract available.

PMID:
20530922
19.
20.

Chronic recurrent multifocal osteomyelitis after acute lymphoblastic leukaemia.

Abril JC, Castillo F, Loewinsonh AF, Rivas C, Bernacer M.

Int Orthop. 1994 Apr;18(2):126-8. Review.

PMID:
8039958

Supplemental Content

Support Center